
Intellectual Property High Court orders generic drug companies to pay approximately JPY 21.7 billion in total in a patent infringement lawsuit (Judgment rendered May 27, 2025)

Kenji Tosaki, Ryo Tonomura (Co-author)
- Dispute Resolution
- IP Disputes
- Intellectual Property
- Pharmaceutical and Healthcare
- Medical, Pharmaceutical and Life Sciences